Latest for Wild-Type ATTR Cardiac Amyloidosis
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial sites17 new sites opened for Study to Learn About the Use of Acoramidis in Patients With a Heart Condition… (Bayer)ClinicalTrials.gov
More about Wild-Type ATTR Cardiac Amyloidosis
Cardiac manifestations include increased wall thickness, restrictive filling patterns, and frequent atrial fibrillation (affecting 40-60% of patients). Importantly, carpal tunnel syndrome often appears about 9 years before the heart disease is diagnosed, providing a potential window for early diagnosis. The disease predominantly affects very elderly males, yet remains profoundly underdiagnosed as symptoms are often attributed to other common conditions.
Keep reading about Wild-Type ATTR Cardiac Amyloidosis
Most people are diagnosed without a biopsy. Once blood and urine tests (serum free light chains and immunofixation) rule out AL amyloidosis, a PYP, DPD or HMDP bone scan showing grade 2 or 3 heart uptake confirms ATTR, and TTR gene sequencing then shows whether it is wild-type or hereditary. A biopsy is needed when the light chain tests are abnormal or the scan is unclear. Recent studies suggest wild-type ATTR may account for 5-10% of heart failure cases in elderly populations.
What are the symptoms of Wild-Type ATTR Cardiac Amyloidosis?
These are common symptoms of Wild-Type ATTR Cardiac Amyloidosis, and how strong they are varies from person to person.
- Shortness of breath and exercise intolerance
- Leg and ankle swelling
- Fatigue and weakness
- Irregular heartbeat or palpitations
- Fainting or near-fainting from conduction abnormalities
- Carpal tunnel syndrome (often about 9 years before the heart disease is diagnosed)
Who gets Wild-Type ATTR Cardiac Amyloidosis?
Wild-type ATTR predominantly affects males over 60 years old, with mean age of symptom onset around 80 years. Male predominance ranges from 75 to 91% in clinical populations. Female cases are increasingly recognized but remain less common.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Wild-Type ATTR Cardiac Amyloidosis?
There are currently 3 FDA-approved medications for Wild-Type ATTR Cardiac Amyloidosis.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Which new Wild-Type ATTR Cardiac Amyloidosis medicines are in trials?
Investigational medicines Trial Friend tracks for Wild-Type ATTR Cardiac Amyloidosis, with trial results, safety findings and where each one stands.
How to get help paying for Wild-Type ATTR Cardiac Amyloidosis treatment
Charity funds and drugmaker programs for Wild-Type ATTR Cardiac Amyloidosis, checked at the source.
- From a charity · NORD RareCareAmyloidosis Medical Assistance fundWaitlist
Pays for: Medical and medication costs.
The foundation says: “Temporarily Waitlisting” - From a charity · NORD RareCareAmyloidosis Premium Copay Assistance fundWaitlist
Pays for: Insurance premiums and copays.
The foundation says: “Temporarily Waitlisting” - From a charity · The Assistance FundAmyloidosis fundWaitlist
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
- Amvuttra (Vutrisiran) · Alnylam Assist
- Vyndamax (Tafamidis) · VynAssist / VyndaLink
- Attruby (Acoramidis) · ForgingBridges
Every program and fund for Wild-Type ATTR Cardiac Amyloidosis, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Wild-Type ATTR Cardiac Amyloidosis
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Wild-Type ATTR Cardiac Amyloidosis resources
Reputable organizations and medical references for learning more about Wild-Type ATTR Cardiac Amyloidosis, including disease registries, foundation resources, and clinical guidelines.